Kopin Reports Results for Third Quarter 2022
Kopin Corporation (Nasdaq: KOPN) reported a 23% increase in total revenues for Q3 2022, reaching $13.4 million compared to $10.9 million in Q3 2021. Defense revenues surged 115%, driving overall growth. However, the company incurred a net loss of $4.5 million, larger than the $2.1 million loss in the same period last year. Cost of product revenues rose to 81% of net revenues, impacted by a $1 million warranty charge due to a vendor quality issue. Cash reserves decreased significantly from $29.3 million at the end of 2021 to $15.0 million by September 2022.
- 23% total revenue growth year-over-year, reaching $13.4 million.
- Defense revenues increased by 115%, indicating strong demand.
- R&D expenses decreased by 8% year-over-year.
- Net loss of $4.5 million, worsening from $2.1 million in Q3 2021.
- Cost of product revenues rose to 81% of net revenues, partly due to a $1 million warranty charge.
- Cash reserves dropped from $29.3 million to $15.0 million within nine months.
-
Total Revenues increase
23% year-over-year -
Defense Revenues Increase
115% year-over-year
“We had a good quarter with revenues up
Murray continued, “As we move into 2023 I see numerous opportunities to drive revenues, beginning with accelerating growth from our defense and industrial businesses, where we already have a solid order book. We will also leverage our unique ability to offer complex integrated optical display assemblies, which are critical to increasing the applications for AR/VR/MR, among other opportunities.”
“Technology has always been at the heart of Kopin’s success and we will continue executing on our vision to provide our global customers with brilliance in innovation, design and performance paired with a renewed focus on operational excellence,” concluded Murray.
Third Quarter Financial Results
Total revenues for the third quarter ended
Cost of Product Revenues for the third quarter of 2022 was
Research and Development (R&D) expenses for the third quarter of 2022 were
Selling, General and Administration (SG&A) expenses were
Other income and expense included a non-cash impairment charge of
Net Loss Attributable to
In
Conference Call
Kopin will host a conference call this morning at
About Kopin
Kopin is a trademark of
Forward-Looking Statements
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements include statements with respect to our numerous opportunities to drive revenues in 2023; such as accelerating growth from our defense and industrial businesses; our growth in the defense and consumer markets; and our intent to leverage our unique ability to offer complex integrated optical display assemblies. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended
Supplemental Information | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||
Display Revenues by Category (in millions) | ||||||||||||
Defense | $ |
7.5 |
$ |
3.5 |
$ |
19.3 |
$ |
12.3 |
||||
Industrial/Enterprise |
|
1.7 |
|
2.7 |
|
4.9 |
|
7.4 |
||||
Consumer |
|
0.7 |
|
0.4 |
|
1.2 |
|
1.3 |
||||
R&D |
|
3.4 |
|
4.1 |
|
11.1 |
|
10.4 |
||||
License and Royalties |
|
0.1 |
|
0.2 |
|
0.4 |
|
1.1 |
||||
Total | $ |
13.4 |
$ |
10.9 |
$ |
36.9 |
$ |
32.5 |
||||
Stock-Based Compensation Expense | ||||||||||||
Cost of product revenues | $ |
42,000 |
$ |
38,000 |
$ |
120,000 |
$ |
207,000 |
||||
Research and development | $ |
112,000 |
|
180,000 |
|
368,000 |
|
395,000 |
||||
Selling, general and administrative | $ |
144,000 |
|
424,000 |
|
883,000 |
|
3,165,000 |
||||
$ |
298,000 |
$ |
642,000 |
$ |
1,371,000 |
$ |
3,767,000 |
|||||
Other Financial Information | ||||||||||||
Depreciation and amortization | $ |
121,000 |
$ |
154,000 |
$ |
656,000 |
$ |
566,000 |
Condensed Consolidated Statements of Operations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
Revenues: | ||||||||||||||||
Net product revenues | $ |
9,903,315 |
|
$ |
6,591,852 |
|
$ |
25,414,501 |
|
$ |
21,089,515 |
|
||||
Research and development and other revenues |
|
3,474,693 |
|
|
4,295,321 |
|
|
11,450,961 |
|
|
11,379,282 |
|
||||
|
13,378,008 |
|
|
10,887,173 |
|
|
36,865,462 |
|
|
32,468,797 |
|
|||||
Expenses: | ||||||||||||||||
Cost of product revenues |
|
7,987,154 |
|
|
5,145,175 |
|
|
23,676,283 |
|
|
17,586,389 |
|
||||
Research and development |
|
3,441,405 |
|
|
3,751,729 |
|
|
13,995,393 |
|
|
11,055,282 |
|
||||
Selling, general and administration |
|
4,320,117 |
|
|
4,035,998 |
|
|
13,112,133 |
|
|
13,982,682 |
|
||||
|
15,748,676 |
|
|
12,932,902 |
|
|
50,783,809 |
|
|
42,624,353 |
|
|||||
Loss from operations |
|
(2,370,668 |
) |
|
(2,045,729 |
) |
|
(13,918,347 |
) |
|
(10,155,556 |
) |
||||
Other (expense) income, net |
|
(2,093,877 |
) |
|
(50,954 |
) |
|
2,505,949 |
|
|
89,267 |
|
||||
Loss before provision for income taxes and net (income) loss from noncontrolling interest |
|
(4,464,545 |
) |
|
(2,096,683 |
) |
|
(11,412,398 |
) |
|
(10,066,289 |
) |
||||
Tax provision |
|
(36,000 |
) |
|
(32,000 |
) |
|
(108,000 |
) |
|
(97,000 |
) |
||||
Net loss |
|
(4,500,545 |
) |
|
(2,128,683 |
) |
|
(11,520,398 |
) |
|
(10,163,289 |
) |
||||
Net (income) loss attributable to noncontrolling interest |
|
- |
|
|
(107 |
) |
|
280 |
|
|
39,394 |
|
||||
Net loss attributable to |
$ |
(4,500,545 |
) |
$ |
(2,128,790 |
) |
$ |
(11,520,118 |
) |
$ |
(10,123,895 |
) |
||||
Net loss per share: | ||||||||||||||||
Basic and diluted | $ |
(0.05 |
) |
$ |
(0.02 |
) |
$ |
(0.13 |
) |
$ |
(0.11 |
) |
||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic and diluted |
|
93,516,231 |
|
|
90,517,330 |
|
|
91,317,288 |
|
|
88,903,658 |
|
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and marketable securities | $ |
14,969,372 |
|
$ |
29,295,466 |
|
||
Accounts receivable, net |
|
8,531,835 |
|
|
12,113,070 |
|
||
Inventory |
|
6,660,810 |
|
|
6,581,139 |
|
||
Contract assets and unbilled receivables |
|
6,254,518 |
|
|
2,299,392 |
|
||
Prepaid and other current assets |
|
1,759,708 |
|
|
1,918,678 |
|
||
Total current assets |
|
38,176,243 |
|
|
52,207,745 |
|
||
Plant and equipment, net |
|
1,627,468 |
|
|
1,888,963 |
|
||
Operating lease right-of-use assets |
|
3,540,073 |
|
|
3,828,066 |
|
||
Other assets |
|
170,932 |
|
|
170,932 |
|
||
Equity investments |
|
7,612,065 |
|
|
4,912,022 |
|
||
Total assets | $ |
51,126,781 |
|
$ |
63,007,728 |
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ |
4,936,932 |
|
$ |
5,483,970 |
|
||
Accrued expenses |
|
7,520,992 |
|
|
4,133,379 |
|
||
Contract liabilities and billings in excess of revenue earned |
|
1,097,919 |
|
|
4,063,031 |
|
||
Operating lease liabilities |
|
761,734 |
|
|
701,204 |
|
||
Customer deposits |
|
378,201 |
|
|
2,638,103 |
|
||
Deferred tax liabilities |
|
424,433 |
|
|
513,417 |
|
||
Total current liabilities |
|
15,120,211 |
|
|
17,533,104 |
|
||
Other long term liabilities |
|
1,395,603 |
|
|
2,739,531 |
|
||
Operating lease liabilities, net of current portion |
|
2,753,885 |
|
|
3,108,236 |
|
||
|
32,029,696 |
|
|
39,799,191 |
|
|||
Noncontrolling interest |
|
(172,614 |
) |
|
(172,334 |
) |
||
Total stockholders' equity |
|
31,857,082 |
|
|
39,626,857 |
|
||
Total liabilities and stockholders' equity | $ |
51,126,781 |
|
$ |
63,007,728 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005503/en/
Investor Contacts:
Kopin
Treasurer and Chief Financial Officer
Richard_Sneider@kopin.com
Or
JHorne@marketstreetpartners.com
Source:
FAQ
What were the total revenues for KOPN in Q3 2022?
How much did defense revenues increase for KOPN in the latest quarter?
What was KOPN's net loss in Q3 2022?